1. Home
  2. Analysis
  3. Atracurium-besylate
  4. Spironolactone

Atracurium besylate and Spironolactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atracurium besylate and Spironolactone. Common interactions include bradycardia among females and propofol infusion syndrome among males.

The phase IV clinical study analyzes what interactions people who take Atracurium besylate and Spironolactone have. It is created by eHealthMe based on reports of 8 people who take Atracurium besylate and Spironolactone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

8 people who take Atracurium besylate and Spironolactone together, and have interactions are studied.

What is Atracurium besylate?

Atracurium besylate has active ingredients of atracurium besylate. eHealthMe is studying from 964 Atracurium besylate users for its effectiveness, alternative drugs and more.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 102,148 Spironolactone users for its effectiveness, alternative drugs and more.

Number of Atracurium besylate and Spironolactone reports submitted per year:

Atracurium besylate and Spironolactone drug interactions.

Common Atracurium Besylate and Spironolactone drug interactions by gender *:

female:

  1. Bradycardia
  2. Bronchospasm
  3. Hypotension
  4. Respiratory failure (excl neonatal)
  5. Sepsis
  6. Wheezing
  7. Oxygen saturation decreased

male:

  1. Propofol infusion syndrome
  2. Rhabdomyolysis
  3. Blood creatine phosphokinase increased
  4. Blood creatinine increased
  5. Blood lactate dehydrogenase increased
  6. Epidermal necrolysis
  7. Peritonitis
  8. Pneumonia
  9. Pulmonary embolism

Common Atracurium Besylate and Spironolactone drug interactions by age *:

0-1:

n/a

2-9:

  1. Bradycardia
  2. Oxygen saturation decreased
  3. Respiratory failure (excl neonatal)
  4. Sepsis

10-19:

  1. Propofol infusion syndrome
  2. Rhabdomyolysis
  3. Blood creatine phosphokinase increased

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bronchospasm
  2. Hypotension
  3. Oxygen saturation decreased
  4. Wheezing

60+:

  1. Blood creatinine increased
  2. Blood lactate dehydrogenase increased
  3. Epidermal necrolysis
  4. Peritonitis
  5. Pneumonia
  6. Pulmonary embolism

* Approximation only. Some reports may have incomplete information.

Do you take Atracurium besylate and Spironolactone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atracurium besylate and Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atracurium besylate side effects:

Browse all side effects of Atracurium besylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spironolactone side effects:

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atracurium besylate interactions:

Browse all interactions between Atracurium besylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spironolactone interactions:

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atracurium besylate and spironolactone (the active ingredients of Atracurium besylate and Spironolactone, respectively), and Atracurium besylate and Spironolactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atracurium besylate and Spironolactone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.